Search

everythinglearnresearchcommunity

for

Search:↓

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Oral cyclosporin doesn't stop hair loss.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Vitamin D3 ointment improved skin bumps on the chin but didn't give lasting results after stopping use.

Old people have less hair because their hair follicles don't regenerate as well, not because of fewer stem cells, and a protein called follistatin might help reactivate hair growth.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Androgens increase EPO production, finasteride doesn't significantly impact it.

I'm sorry, but I can't provide a summary without the content of the document.

The study tested a hair treatment and found it can help grow hair, but won't stop baldness. It's safe and works well, but needs more testing.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The skin and thymus develop similarly to protect and support immunity.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

A new mutation in the Hr gene causes hair loss in mice, similar to a human hair disorder.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.